Array Behavioral Care launched a new service to help providers assess patients with urgent behavioral health needs and ...

Since implementing AI clinical documentation improvement (CDI) tools, Intermountain has seen a 22% point increase in ...

A growing group of companies is developing new immunology drugs to challenge Dupixent, the blockbuster Sanofi product with a dominating presence in multiple inflammatory indications. North Immunology ...

The Series C funding round was from The General Partnership, Index Ventures, General Catalyst and Andreessen Horowitz.

Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall.

HHS Secretary Robert F. Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force this week, completing ...

As Medicare Advantage denial rates climb, health systems are dropping plans and steering patients back to traditional ...

Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective ...

The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...

Ayble Health’s Series A round was led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic ...

Ultragenyx Pharmaceutical’s Fayuvi is now the first FDA-approved therapy for the underlying cause of Sanfilippo syndrome type ...